Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo‐Controlled, Crossover Comparison ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-01

AUTHORS

D J Angiolillo, C M Gibson, S Cheng, C Ollier, O Nicolas, L Bergougnan, L Perrin, F P LaCreta, F Hurbin, M Dubar

ABSTRACT

Four randomized, placebo-controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between clopidogrel (300-mg loading dose/75-mg/day maintenance dose) and the proton-pump inhibitor (PPI) omeprazole (80 mg) when they are administered simultaneously (study 1); whether the interaction, if any, can be mitigated by administering clopidogrel and omeprazole 12 h apart (study 2) or by increasing clopidogrel to 600-mg loading/150-mg/day maintenance dosing (study 3); and whether the interaction applies equally to the PPI pantoprazole (80 mg) (study 4). Relative to levels after administration of clopidogrel alone in studies 1,2,3, and 4, coadministration of PPI decreased the AUC(0-24) of the clopidogrel active metabolite H4 by 40, 47, 41, and 14% (P ≤ 0.002), respectively; increased maximal platelet aggregation (MPA) induced by 5 micromol/l adenosine diphosphate (ADP) by 8.0, 5.6, 8.1, and 4.3% (P ≤ 0.014), respectively; and increased the vasodilator-stimulated phosphoprotein phosphorylation-platelet reactivity index (VASP-PRI) by 20.7, 27.1, 19.0 (P < 0.0001), and 3.9% (P = 0.3319), respectively. The results suggest that a metabolic drug-drug interaction exists between clopidogrel and omeprazole but not between clopidogrel and pantoprazole. More... »

PAGES

65-74

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/clpt.2010.219

DOI

http://dx.doi.org/10.1038/clpt.2010.219

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005543528

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20844485


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "2-Pyridinylmethylsulfinylbenzimidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aryl Hydrocarbon Hydroxylases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP2C19", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Half-Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Omeprazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prodrugs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proton Pump Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ticlopidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Florida", 
          "id": "https://www.grid.ac/institutes/grid.15276.37", 
          "name": [
            "University of Florida College of Medicine Division of Cardiology Jacksonville Florida USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Angiolillo", 
        "givenName": "D J", 
        "id": "sg:person.01144446702.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144446702.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Beth Israel Deaconess Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.239395.7", 
          "name": [
            "Beth Israel Deaconess Medical Center Division of Cardiology Boston Massachusetts USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gibson", 
        "givenName": "C M", 
        "id": "sg:person.0750215673.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750215673.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Clinical and Exploratory Pharmacology sanofi\u2010aventis Bridgewater New Jersey USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheng", 
        "givenName": "S", 
        "id": "sg:person.01064415701.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064415701.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "sanofi\u2010aventis Recherche D\u00e9veloppement Global Metabolism and Pharmacokinetic Department Montpellier France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ollier", 
        "givenName": "C", 
        "id": "sg:person.01241440773.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241440773.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "sanofi\u2010aventis Recherche D\u00e9veloppement Global Metabolism and Pharmacokinetic Department Montpellier France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nicolas", 
        "givenName": "O", 
        "id": "sg:person.01014221442.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014221442.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "sanofi\u2010aventis Recherche D\u00e9veloppement Clinical Pharmacology and Exploratory Department Chilly Mazarin France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bergougnan", 
        "givenName": "L", 
        "id": "sg:person.011007435754.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011007435754.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sanofi\u2010aventis Recherche D\u00e9veloppement Biostatistics Department Montpellier France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perrin", 
        "givenName": "L", 
        "id": "sg:person.0632263273.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632263273.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol\u2010Myers Squibb Discovery Medicine and Clinical Pharmacology Princeton New Jersey USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "LaCreta", 
        "givenName": "F P", 
        "id": "sg:person.01270776065.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270776065.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "sanofi\u2010aventis Recherche D\u00e9veloppement Global Metabolism and Pharmacokinetic Department Montpellier France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hurbin", 
        "givenName": "F", 
        "id": "sg:person.01243116401.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243116401.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "sanofi\u2010aventis Recherche D\u00e9veloppement Clinical Pharmacology and Exploratory Department Chilly Mazarin France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dubar", 
        "givenName": "M", 
        "id": "sg:person.01014625073.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014625073.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1161/circulationaha.108.191087", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001730718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.109.873497", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002380319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2008.05.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002925712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/clc.20721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004251687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2006.02162.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004917108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1503/cmaj.082001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009932566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1503/cmaj.082001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009932566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/00365510902971875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017399895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1067/mcp.2001.114231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019407656", 
          "https://doi.org/10.1067/mcp.2001.114231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.109.029132", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019525658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0828-282x(10)70008-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019929128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2009.261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020853879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200629090-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021468837", 
          "https://doi.org/10.2165/00002018-200629090-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2009.10.063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022835849"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2007.06.064", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027572534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2006.09.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027660345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2036.2010.04247.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034269342"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2006.11.044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036520525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.30.11.1288", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036849748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinternmed.2010.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037525034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0809171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039584602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.32.8.821", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040733094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(09)61525-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043432479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrcardio.2009.60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044078837", 
          "https://doi.org/10.1038/nrcardio.2009.60"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2006.06.065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049291775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/dhps.s7297", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049441984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007990802205985", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050802214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-152-6-201003160-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073711401"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-01", 
    "datePublishedReg": "2011-01-01", 
    "description": "Four randomized, placebo-controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between clopidogrel (300-mg loading dose/75-mg/day maintenance dose) and the proton-pump inhibitor (PPI) omeprazole (80 mg) when they are administered simultaneously (study 1); whether the interaction, if any, can be mitigated by administering clopidogrel and omeprazole 12 h apart (study 2) or by increasing clopidogrel to 600-mg loading/150-mg/day maintenance dosing (study 3); and whether the interaction applies equally to the PPI pantoprazole (80 mg) (study 4). Relative to levels after administration of clopidogrel alone in studies 1,2,3, and 4, coadministration of PPI decreased the AUC(0-24) of the clopidogrel active metabolite H4 by 40, 47, 41, and 14% (P \u2264 0.002), respectively; increased maximal platelet aggregation (MPA) induced by 5 micromol/l adenosine diphosphate (ADP) by 8.0, 5.6, 8.1, and 4.3% (P \u2264 0.014), respectively; and increased the vasodilator-stimulated phosphoprotein phosphorylation-platelet reactivity index (VASP-PRI) by 20.7, 27.1, 19.0 (P < 0.0001), and 3.9% (P = 0.3319), respectively. The results suggest that a metabolic drug-drug interaction exists between clopidogrel and omeprazole but not between clopidogrel and pantoprazole.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/clpt.2010.219", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "89"
      }
    ], 
    "name": "Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo\u2010Controlled, Crossover Comparison Studies", 
    "pagination": "65-74", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1a69af6e5197fdcd5cbb470908ee43b4325cd3a343faf0d9ff95da73d35ed7fa"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20844485"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/clpt.2010.219"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005543528"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/clpt.2010.219", 
      "https://app.dimensions.ai/details/publication/pub.1005543528"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000306.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1038/clpt.2010.219/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/clpt.2010.219'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/clpt.2010.219'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/clpt.2010.219'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/clpt.2010.219'


 

This table displays all metadata directly associated to this object as RDF triples.

324 TRIPLES      21 PREDICATES      78 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/clpt.2010.219 schema:about N1e245ffab433484f93f54f38d618d686
2 N2f4977442b2745ca90666e0ff3a9bf0d
3 N504a62c293234cc2ac27ae7e3fdce0d1
4 N5672173be391488386f8ac0969802d61
5 N5b23c520e80946b1b193947bd1f49cec
6 N751ae9354b354d40a1b27e2987439bd0
7 N762a948df8124fbdb8416906284b7767
8 N787b88eab52144799fcc822774eec7ed
9 N78ea0f8b4b6d4a2bb295adc0fa18cbb7
10 N89eae874e1c9425c8f7a4598556c314a
11 N8fda7d6e2144463492658d340e0055ae
12 N942f2c5757354f62a10804e703edeb0d
13 N972cb79198b543b58aecfa1a5c304785
14 N9e8c1998ad1a4b73b0e98ae6d3f69e91
15 N9f6350e89b3f4890851dc7981b8d3f43
16 Na20189e56c1f41f4ac09faa8d9ffd7e8
17 Na74123209c2d4aacb5e34ae9e0f5a9d5
18 Nbce5d79ba0fa4c03abca21a15a60fcc3
19 Nc611a6aff2b64d5aad7bf8e6529bfdb8
20 Nd3184df827e244f983eb0ddeefc0abe4
21 Ndc847eb8c518480fbb649ff7a311d6d0
22 Nf8c7c7bf778947f38bcf8c0b47151275
23 anzsrc-for:11
24 anzsrc-for:1117
25 schema:author N5b2df600dae24dc3a3fb48d6850667d7
26 schema:citation sg:pub.10.1038/nrcardio.2009.60
27 sg:pub.10.1067/mcp.2001.114231
28 sg:pub.10.2165/00002018-200629090-00002
29 https://doi.org/10.1001/archinternmed.2010.34
30 https://doi.org/10.1001/jama.2009.261
31 https://doi.org/10.1002/clc.20721
32 https://doi.org/10.1016/j.amjcard.2006.09.008
33 https://doi.org/10.1016/j.amjcard.2009.10.063
34 https://doi.org/10.1016/j.jacc.2006.06.065
35 https://doi.org/10.1016/j.jacc.2006.11.044
36 https://doi.org/10.1016/j.jacc.2007.06.064
37 https://doi.org/10.1016/j.jacc.2008.05.053
38 https://doi.org/10.1016/s0140-6736(09)61525-7
39 https://doi.org/10.1016/s0828-282x(10)70008-8
40 https://doi.org/10.1056/nejmoa0809171
41 https://doi.org/10.1111/j.1365-2036.2010.04247.x
42 https://doi.org/10.1111/j.1538-7836.2006.02162.x
43 https://doi.org/10.1124/dmd.109.029132
44 https://doi.org/10.1124/dmd.30.11.1288
45 https://doi.org/10.1124/dmd.32.8.821
46 https://doi.org/10.1161/circulationaha.108.191087
47 https://doi.org/10.1161/circulationaha.109.873497
48 https://doi.org/10.1185/03007990802205985
49 https://doi.org/10.1503/cmaj.082001
50 https://doi.org/10.2147/dhps.s7297
51 https://doi.org/10.3109/00365510902971875
52 https://doi.org/10.7326/0003-4819-152-6-201003160-00003
53 schema:datePublished 2011-01
54 schema:datePublishedReg 2011-01-01
55 schema:description Four randomized, placebo-controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between clopidogrel (300-mg loading dose/75-mg/day maintenance dose) and the proton-pump inhibitor (PPI) omeprazole (80 mg) when they are administered simultaneously (study 1); whether the interaction, if any, can be mitigated by administering clopidogrel and omeprazole 12 h apart (study 2) or by increasing clopidogrel to 600-mg loading/150-mg/day maintenance dosing (study 3); and whether the interaction applies equally to the PPI pantoprazole (80 mg) (study 4). Relative to levels after administration of clopidogrel alone in studies 1,2,3, and 4, coadministration of PPI decreased the AUC(0-24) of the clopidogrel active metabolite H4 by 40, 47, 41, and 14% (P ≤ 0.002), respectively; increased maximal platelet aggregation (MPA) induced by 5 micromol/l adenosine diphosphate (ADP) by 8.0, 5.6, 8.1, and 4.3% (P ≤ 0.014), respectively; and increased the vasodilator-stimulated phosphoprotein phosphorylation-platelet reactivity index (VASP-PRI) by 20.7, 27.1, 19.0 (P < 0.0001), and 3.9% (P = 0.3319), respectively. The results suggest that a metabolic drug-drug interaction exists between clopidogrel and omeprazole but not between clopidogrel and pantoprazole.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree false
59 schema:isPartOf N1cf9cfe76d1b41b79376ceabdccb6b93
60 N55a9910d97314e4181435cb91a01f066
61 sg:journal.1017409
62 schema:name Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo‐Controlled, Crossover Comparison Studies
63 schema:pagination 65-74
64 schema:productId N0d6654cd14c04cf39de38ef8ec199b26
65 N1109a36bd8a043a4aeb7bfe43a3bb127
66 Na4ee372e7b9c466f9725aa63336634ba
67 Nbd5d1d9573e54918bff75920b850dda8
68 Necbe56b1752d4210a46820ad326b1b9b
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005543528
70 https://doi.org/10.1038/clpt.2010.219
71 schema:sdDatePublished 2019-04-10T23:03
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N530dcd6dec524208b8c37d8350552f68
74 schema:url http://onlinelibrary.wiley.com/doi/10.1038/clpt.2010.219/abstract
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N05b8d1a4ed8d49dd802838de532523b8 schema:name Clinical and Exploratory Pharmacology sanofi‐aventis Bridgewater New Jersey USA
79 rdf:type schema:Organization
80 N0d6654cd14c04cf39de38ef8ec199b26 schema:name readcube_id
81 schema:value 1a69af6e5197fdcd5cbb470908ee43b4325cd3a343faf0d9ff95da73d35ed7fa
82 rdf:type schema:PropertyValue
83 N109eb581bab643afbb8bf303a2b9dd2a schema:name sanofi‐aventis Recherche Développement Clinical Pharmacology and Exploratory Department Chilly Mazarin France
84 rdf:type schema:Organization
85 N1109a36bd8a043a4aeb7bfe43a3bb127 schema:name nlm_unique_id
86 schema:value 0372741
87 rdf:type schema:PropertyValue
88 N1cf9cfe76d1b41b79376ceabdccb6b93 schema:volumeNumber 89
89 rdf:type schema:PublicationVolume
90 N1e245ffab433484f93f54f38d618d686 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Drug Interactions
92 rdf:type schema:DefinedTerm
93 N2e86bbf3f32c437ea682d98a540296ae rdf:first sg:person.01243116401.57
94 rdf:rest Neee1b55520484937ad7624d5be0c7b78
95 N2f4977442b2745ca90666e0ff3a9bf0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adult
97 rdf:type schema:DefinedTerm
98 N40cf3459eb9341b3bb55bff06ca22ea2 schema:name sanofi‐aventis Recherche Développement Global Metabolism and Pharmacokinetic Department Montpellier France
99 rdf:type schema:Organization
100 N4f043634cee34f5ab71aee4ce7204c86 rdf:first sg:person.01241440773.72
101 rdf:rest N6338d2a9f4454fc0a32f885cc1523fa8
102 N504a62c293234cc2ac27ae7e3fdce0d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Platelet Activation
104 rdf:type schema:DefinedTerm
105 N530dcd6dec524208b8c37d8350552f68 schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 N55a9910d97314e4181435cb91a01f066 schema:issueNumber 1
108 rdf:type schema:PublicationIssue
109 N5672173be391488386f8ac0969802d61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Omeprazole
111 rdf:type schema:DefinedTerm
112 N5b23c520e80946b1b193947bd1f49cec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Aryl Hydrocarbon Hydroxylases
114 rdf:type schema:DefinedTerm
115 N5b2df600dae24dc3a3fb48d6850667d7 rdf:first sg:person.01144446702.77
116 rdf:rest Nc02880bbf6a44325b18b82eee5afca4d
117 N6338d2a9f4454fc0a32f885cc1523fa8 rdf:first sg:person.01014221442.20
118 rdf:rest Na88ee489ed2747e7867d7c42e1fc9b61
119 N6e96aa80f55640fb9a400edcae984dd3 schema:name sanofi‐aventis Recherche Développement Global Metabolism and Pharmacokinetic Department Montpellier France
120 rdf:type schema:Organization
121 N727e6ce53f374a74bff36a3324eacdbb rdf:first sg:person.0632263273.88
122 rdf:rest Neb583c6f3f714022853534c31eda61a5
123 N751ae9354b354d40a1b27e2987439bd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Platelet Aggregation
125 rdf:type schema:DefinedTerm
126 N762a948df8124fbdb8416906284b7767 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Female
128 rdf:type schema:DefinedTerm
129 N787b88eab52144799fcc822774eec7ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Drug Administration Schedule
131 rdf:type schema:DefinedTerm
132 N78ea0f8b4b6d4a2bb295adc0fa18cbb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Cross-Over Studies
134 rdf:type schema:DefinedTerm
135 N7bc3ce54e1bd469da0d21abbb10f1245 rdf:first sg:person.01064415701.95
136 rdf:rest N4f043634cee34f5ab71aee4ce7204c86
137 N89eae874e1c9425c8f7a4598556c314a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Male
139 rdf:type schema:DefinedTerm
140 N8fda7d6e2144463492658d340e0055ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Prodrugs
142 rdf:type schema:DefinedTerm
143 N942f2c5757354f62a10804e703edeb0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Half-Life
145 rdf:type schema:DefinedTerm
146 N972cb79198b543b58aecfa1a5c304785 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Middle Aged
148 rdf:type schema:DefinedTerm
149 N9e8c1998ad1a4b73b0e98ae6d3f69e91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Young Adult
151 rdf:type schema:DefinedTerm
152 N9f6350e89b3f4890851dc7981b8d3f43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name 2-Pyridinylmethylsulfinylbenzimidazoles
154 rdf:type schema:DefinedTerm
155 Na20189e56c1f41f4ac09faa8d9ffd7e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Enzyme Inhibitors
157 rdf:type schema:DefinedTerm
158 Na4ee372e7b9c466f9725aa63336634ba schema:name doi
159 schema:value 10.1038/clpt.2010.219
160 rdf:type schema:PropertyValue
161 Na74123209c2d4aacb5e34ae9e0f5a9d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Cytochrome P-450 CYP2C19
163 rdf:type schema:DefinedTerm
164 Na88ee489ed2747e7867d7c42e1fc9b61 rdf:first sg:person.011007435754.00
165 rdf:rest N727e6ce53f374a74bff36a3324eacdbb
166 Nb4f8edcde9c04cc290136f563160c89b schema:name sanofi‐aventis Recherche Développement Clinical Pharmacology and Exploratory Department Chilly Mazarin France
167 rdf:type schema:Organization
168 Nbce5d79ba0fa4c03abca21a15a60fcc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Humans
170 rdf:type schema:DefinedTerm
171 Nbd5d1d9573e54918bff75920b850dda8 schema:name dimensions_id
172 schema:value pub.1005543528
173 rdf:type schema:PropertyValue
174 Nc02880bbf6a44325b18b82eee5afca4d rdf:first sg:person.0750215673.07
175 rdf:rest N7bc3ce54e1bd469da0d21abbb10f1245
176 Nc611a6aff2b64d5aad7bf8e6529bfdb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Double-Blind Method
178 rdf:type schema:DefinedTerm
179 Nd3184df827e244f983eb0ddeefc0abe4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Platelet Aggregation Inhibitors
181 rdf:type schema:DefinedTerm
182 Ndc847eb8c518480fbb649ff7a311d6d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Proton Pump Inhibitors
184 rdf:type schema:DefinedTerm
185 Neb583c6f3f714022853534c31eda61a5 rdf:first sg:person.01270776065.21
186 rdf:rest N2e86bbf3f32c437ea682d98a540296ae
187 Necbe56b1752d4210a46820ad326b1b9b schema:name pubmed_id
188 schema:value 20844485
189 rdf:type schema:PropertyValue
190 Nee6f09fd21f94334aa57195a19c7b8e0 schema:name Sanofi‐aventis Recherche Développement Biostatistics Department Montpellier France
191 rdf:type schema:Organization
192 Neee1b55520484937ad7624d5be0c7b78 rdf:first sg:person.01014625073.14
193 rdf:rest rdf:nil
194 Nf8c7c7bf778947f38bcf8c0b47151275 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Ticlopidine
196 rdf:type schema:DefinedTerm
197 Nf9314d7596b44de08b6331efd2809ae4 schema:name sanofi‐aventis Recherche Développement Global Metabolism and Pharmacokinetic Department Montpellier France
198 rdf:type schema:Organization
199 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
200 schema:name Medical and Health Sciences
201 rdf:type schema:DefinedTerm
202 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
203 schema:name Public Health and Health Services
204 rdf:type schema:DefinedTerm
205 sg:journal.1017409 schema:issn 0009-9236
206 1532-6535
207 schema:name Clinical Pharmacology & Therapeutics
208 rdf:type schema:Periodical
209 sg:person.01014221442.20 schema:affiliation Nf9314d7596b44de08b6331efd2809ae4
210 schema:familyName Nicolas
211 schema:givenName O
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014221442.20
213 rdf:type schema:Person
214 sg:person.01014625073.14 schema:affiliation Nb4f8edcde9c04cc290136f563160c89b
215 schema:familyName Dubar
216 schema:givenName M
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014625073.14
218 rdf:type schema:Person
219 sg:person.01064415701.95 schema:affiliation N05b8d1a4ed8d49dd802838de532523b8
220 schema:familyName Cheng
221 schema:givenName S
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064415701.95
223 rdf:type schema:Person
224 sg:person.011007435754.00 schema:affiliation N109eb581bab643afbb8bf303a2b9dd2a
225 schema:familyName Bergougnan
226 schema:givenName L
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011007435754.00
228 rdf:type schema:Person
229 sg:person.01144446702.77 schema:affiliation https://www.grid.ac/institutes/grid.15276.37
230 schema:familyName Angiolillo
231 schema:givenName D J
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144446702.77
233 rdf:type schema:Person
234 sg:person.01241440773.72 schema:affiliation N40cf3459eb9341b3bb55bff06ca22ea2
235 schema:familyName Ollier
236 schema:givenName C
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241440773.72
238 rdf:type schema:Person
239 sg:person.01243116401.57 schema:affiliation N6e96aa80f55640fb9a400edcae984dd3
240 schema:familyName Hurbin
241 schema:givenName F
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243116401.57
243 rdf:type schema:Person
244 sg:person.01270776065.21 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
245 schema:familyName LaCreta
246 schema:givenName F P
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270776065.21
248 rdf:type schema:Person
249 sg:person.0632263273.88 schema:affiliation Nee6f09fd21f94334aa57195a19c7b8e0
250 schema:familyName Perrin
251 schema:givenName L
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632263273.88
253 rdf:type schema:Person
254 sg:person.0750215673.07 schema:affiliation https://www.grid.ac/institutes/grid.239395.7
255 schema:familyName Gibson
256 schema:givenName C M
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750215673.07
258 rdf:type schema:Person
259 sg:pub.10.1038/nrcardio.2009.60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044078837
260 https://doi.org/10.1038/nrcardio.2009.60
261 rdf:type schema:CreativeWork
262 sg:pub.10.1067/mcp.2001.114231 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019407656
263 https://doi.org/10.1067/mcp.2001.114231
264 rdf:type schema:CreativeWork
265 sg:pub.10.2165/00002018-200629090-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021468837
266 https://doi.org/10.2165/00002018-200629090-00002
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1001/archinternmed.2010.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037525034
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1001/jama.2009.261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020853879
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1002/clc.20721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004251687
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1016/j.amjcard.2006.09.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027660345
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1016/j.amjcard.2009.10.063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022835849
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1016/j.jacc.2006.06.065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049291775
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1016/j.jacc.2006.11.044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036520525
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1016/j.jacc.2007.06.064 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027572534
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1016/j.jacc.2008.05.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002925712
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/s0140-6736(09)61525-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043432479
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/s0828-282x(10)70008-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019929128
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1056/nejmoa0809171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039584602
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1111/j.1365-2036.2010.04247.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034269342
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1111/j.1538-7836.2006.02162.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004917108
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1124/dmd.109.029132 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019525658
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1124/dmd.30.11.1288 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036849748
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1124/dmd.32.8.821 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040733094
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1161/circulationaha.108.191087 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001730718
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1161/circulationaha.109.873497 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002380319
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1185/03007990802205985 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050802214
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1503/cmaj.082001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009932566
309 rdf:type schema:CreativeWork
310 https://doi.org/10.2147/dhps.s7297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049441984
311 rdf:type schema:CreativeWork
312 https://doi.org/10.3109/00365510902971875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017399895
313 rdf:type schema:CreativeWork
314 https://doi.org/10.7326/0003-4819-152-6-201003160-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073711401
315 rdf:type schema:CreativeWork
316 https://www.grid.ac/institutes/grid.15276.37 schema:alternateName University of Florida
317 schema:name University of Florida College of Medicine Division of Cardiology Jacksonville Florida USA
318 rdf:type schema:Organization
319 https://www.grid.ac/institutes/grid.239395.7 schema:alternateName Beth Israel Deaconess Medical Center
320 schema:name Beth Israel Deaconess Medical Center Division of Cardiology Boston Massachusetts USA
321 rdf:type schema:Organization
322 https://www.grid.ac/institutes/grid.419971.3 schema:alternateName Bristol-Myers Squibb (United States)
323 schema:name Bristol‐Myers Squibb Discovery Medicine and Clinical Pharmacology Princeton New Jersey USA
324 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...